Status:

COMPLETED

Study Comparing Veliparib Plus FOLFIRI Versus Placebo Plus FOLFIRI With or Without Bevacizumab in Previously Untreated Metastatic Colorectal Cancer

Lead Sponsor:

AbbVie

Conditions:

Untreated Metastatic Colorectal Cancer

Eligibility:

All Genders

18-99 years

Phase:

PHASE2

Brief Summary

This was a blinded, randomized, placebo-controlled Phase 2 multicenter study evaluating the efficacy and tolerability of veliparib plus irinotecan, fluorouracil, and leucovorin chemotherapy regimen (F...

Detailed Description

Participants were randomized to one of 2 groups: veliparib plus FOLFIRI ± bevacizumab (veliparib group) or placebo plus FOLFIRI ± bevacizumab (placebo group), and stratified by planned use of bevacizu...

Eligibility Criteria

Inclusion

  • Histologically or cytologically confirmed metastatic adenocarcinoma of the colon or rectum
  • At least 1 unresectable lesion on a CT (Computerized Tomography) scan that is measurable as defined by Response Evaluation Criteria in Solid Tumors (RECIST), Version 1.1
  • ECOG (Eastern Cooperative Oncology Group) performance score of 0 or 1
  • Adequate hematologic, renal and hepatic function

Exclusion

  • Prior anti-cancer treatment for metastatic colorectal cancer
  • Prior exposure to PARP (poly ADP-ribose polymerase) inhibitors
  • The last course of adjuvant or neoadjuvant chemotherapy must have ended \> 12 months prior to Cycle 1 Day -2
  • Any clinically significant and uncontrolled major medical condition
  • Participant is pregnant or lactating
  • Any medical condition, which in the opinion of the study Investigator, places the participant at an unacceptably high risk for toxicities
  • For those receiving bevacizumab, standard medical exclusionary conditions apply

Key Trial Info

Start Date :

December 2 2014

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 22 2017

Estimated Enrollment :

130 Patients enrolled

Trial Details

Trial ID

NCT02305758

Start Date

December 2 2014

End Date

September 22 2017

Last Update

November 20 2018

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Study Comparing Veliparib Plus FOLFIRI Versus Placebo Plus FOLFIRI With or Without Bevacizumab in Previously Untreated Metastatic Colorectal Cancer | DecenTrialz